Literature DB >> 26821893

An effective approach to chronic kidney disease in South Africa.

Mohammed Rafique Moosa1, Anthony M Meyers, Errol Gottlich, Sarala Naicker.   

Abstract

Very few patients with end-stage kidney disease in South Africa receive renal replacement treatment (RRT), despite the rapidly growing demand, because of resource constraints. Nephrologists who agonise daily about who to treat and who not to, and have been doing so since the inception of dialysis in this country, welcomed the opportunity to interact with the National Department of Health at a recent summit of stakeholders. The major challenges were identified and recommendations for short- to long-term solutions were made. While the renal community can still improve efficiencies, it is clear that much of the responsibility for improving access to RRT and reducing inequities must be borne by the national government. The summit marks the first step in a process that we hope will ultimately culminate in universal access to RRT for all South Africans.

Entities:  

Mesh:

Year:  2016        PMID: 26821893     DOI: 10.7196/SAMJ.2016.v106i2.9928

Source DB:  PubMed          Journal:  S Afr Med J


  8 in total

1.  Survival of South African patients on renal replacement therapy.

Authors:  Thabiet Jardine; Esther Wong; Retha Steenkamp; Fergus J Caskey; Mogamat Razeen Davids
Journal:  Clin Kidney J       Date:  2020-03-04

Review 2.  Nephrology in South Africa: Not Yet ubuntu.

Authors:  Nicola Wearne; Ikechi G Okpechi; Charles R Swanepoel
Journal:  Kidney Dis (Basel)       Date:  2019-03-22

3.  Use of the 'Accountability for Reasonableness' Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country.

Authors:  Mohammed Rafique Moosa; Jonathan David Maree; Maxwell T Chirehwa; Solomon R Benatar
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

4.  A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa.

Authors:  Letlhogonolo Makhele; Moliehi Matlala; Mncengeli Sibanda; Antony P Martin; Brian Godman
Journal:  Pharmacoecon Open       Date:  2019-12

5.  The influence of haemodialysis on CD4+ T-cell counts in people living with human immunodeficiency virus with end-stage kidney disease.

Authors:  Melanie Pretorius; Estee Benade; June Fabian; Denise Lawrie; Elizabeth S Mayne
Journal:  South Afr J HIV Med       Date:  2020-12-21       Impact factor: 2.744

6.  Psychometric properties of the kidney disease quality of life-36 (KDQOL-36) in Ethiopian patients undergoing hemodialysis.

Authors:  Mignote Hailu Gebrie; Hussen Mekonnen Asfaw; Workagegnehu Hailu Bilchut; Helena Lindgren; Lena Wettergren
Journal:  Health Qual Life Outcomes       Date:  2022-02-10       Impact factor: 3.186

7.  Risk factors and outcomes of acute kidney injury in South African critically ill adults: a prospective cohort study.

Authors:  Ryan E Aylward; Elizabeth van der Merwe; Sisa Pazi; Minette van Niekerk; Jason Ensor; Debbie Baker; Robert J Freercks
Journal:  BMC Nephrol       Date:  2019-12-10       Impact factor: 2.388

8.  Prevalence and Risk Factors Associated With Chronic Kidney Disease Among Patients Presenting at a Haemodialysis Unit in Dodoma, Tanzania.

Authors:  Alfred J Meremo; Matobogolo B Masalu; Issa Sabi; David P Ngilangwa; Janet Kapinga; Rehema Tagalile; Mariam J Munyogwa; Masumbuko Y Mwashambwa
Journal:  East Afr Health Res J       Date:  2018-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.